MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.500
+0.020 (1.35%)
At close: Sep 17, 2025, 4:00 PM EDT
1.500
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:39 PM EDT
MaxCyte Stock Forecast
Stock Price Forecast
The 2 analysts that cover MaxCyte stock have a consensus rating of "Buy" and an average price target of $7.50, which forecasts a 400.00% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $9.00.
Price Target: $7.50 (+400.00%)
Analyst Consensus: Buy
* Price targets were last updated on Jul 22, 2025.
Analyst Ratings
The average analyst rating for MaxCyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 11, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +300.00% | Jul 22, 2025 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +500.00% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +633.33% | Apr 23, 2024 |
Financial Forecast
Revenue This Year
37.13M
from 38.63M
Decreased by -3.87%
Revenue Next Year
42.62M
from 37.13M
Increased by 14.79%
EPS This Year
-0.43
from -0.39
EPS Next Year
-0.43
from -0.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 39.3M | 46.9M | |||
| Avg | 37.1M | 42.6M | |||
| Low | 33.9M | 38.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.7% | 26.3% | |||
| Avg | -3.9% | 14.8% | |||
| Low | -12.3% | 4.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.38 | -0.35 | |
| Avg | -0.43 | -0.43 | |
| Low | -0.46 | -0.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.